After grilling the CEOs of Merck, J&J and Bristol Myers Squibb (BMS) about high drug prices earlier this year, Bernie Sanders is now going after Novo Nordisk and the high prices of its blockbuster GLP-1 drugs Ozempic and Wegovy. Sanders announced this week that he was launching an investigation into the “outrageously high” prices of […]